Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Weber

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Journal of Medicinal Chemistry|December 23, 2016
Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical BiologyIvana Mejdrová, Dominika Chalupská, Pavla Plačková, et al.
Scientific Reports|June 6, 2023
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLMikolaj Zmudzinski, Wioletta Rut, Kamila Olech, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2011
Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapyJan Weber, Ana C Vazquez, Dane Winner, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 ReplicationIlona Bereczki, Henrietta Papp, Anett Kuczmog, et al.
Journal of Clinical Microbiology|March 15, 2013
Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropismJan Weber, Ana C Vazquez, Dane Winner, et al.
Scientific Reports|September 26, 2022
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteriaIlona Bereczki, Vladimir Vimberg, Eszter Lőrincz, et al.
Journal of Cannabis Research|February 6, 2026
Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agentsFerenc Dániel Petróczi, Angéla Tótik, Miklós Bege, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase InhibitorsAkshatKumar Nigam, Matthew F D Hurley, Fengling Li, et al.
Nature Materials|December 19, 2017
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanismValeria Cagno, Patrizia Andreozzi, Marco D'Alicarnasso, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Journal of Medicinal Chemistry|December 23, 2016
Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical BiologyIvana Mejdrová, Dominika Chalupská, Pavla Plačková, et al.
Scientific Reports|June 6, 2023
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLMikolaj Zmudzinski, Wioletta Rut, Kamila Olech, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2011
Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapyJan Weber, Ana C Vazquez, Dane Winner, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 ReplicationIlona Bereczki, Henrietta Papp, Anett Kuczmog, et al.
Journal of Clinical Microbiology|March 15, 2013
Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropismJan Weber, Ana C Vazquez, Dane Winner, et al.
Scientific Reports|September 26, 2022
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteriaIlona Bereczki, Vladimir Vimberg, Eszter Lőrincz, et al.
Journal of Cannabis Research|February 6, 2026
Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agentsFerenc Dániel Petróczi, Angéla Tótik, Miklós Bege, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase InhibitorsAkshatKumar Nigam, Matthew F D Hurley, Fengling Li, et al.
Nature Materials|December 19, 2017
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanismValeria Cagno, Patrizia Andreozzi, Marco D'Alicarnasso, et al.
Pageof 14